These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23320798)

  • 21. Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder.
    May M; Bastian PJ; Burger M; Bolenz C; Trojan L; Herrmann E; Wülfing C; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Otto W; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Wieland WF; Fritsche HM
    BJU Int; 2011 Oct; 108(8 Pt 2):E278-83. PubMed ID: 21699644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy.
    Wiesner C; Pfitzenmaier J; Faldum A; Gillitzer R; Melchior SW; Thüroff JW
    BJU Int; 2005 Feb; 95(3):301-5. PubMed ID: 15679782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CLINICO-PATHOLOGICAL PATTERN, CLASSIFICATION AND STAGING OF URINARY BLADDER CARCINOMAS--A FIVE YEARS EXPERIENCE AT A TERTIARY CARE HOSPITAL IN CENTRAL PUNJAB.
    Naeem A; Naseem N; Anwar S; Butt S; Nagi AH
    J Ayub Med Coll Abbottabad; 2015; 27(1):131-4. PubMed ID: 26182758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment strategy for bladder cancer in patients on hemodialysis: a clinical review of 28 cases.
    Sato Y; Kondo T; Takagi T; Junpei I; Tanabe K
    Int Urol Nephrol; 2016 Apr; 48(4):503-9. PubMed ID: 26759324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder.
    May M; Bastian PJ; Brookman-May S; Burger M; Bolenz C; Trojan L; Michel MS; Herrmann E; Wülfing C; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Gilfrich C; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Gunia S; Fritsche HM
    Scand J Urol Nephrol; 2011 Sep; 45(4):251-7. PubMed ID: 21388337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
    Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
    BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    da Silva RD; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Chade D; Guglielmetti GB; Pycha A; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Zerbib M; Scherr DS; Shariat SF
    J Urol; 2013 Aug; 190(2):487-92. PubMed ID: 23395802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of the diagnostic process in patients presenting with symptoms suggestive of bladder or kidney cancer: a systematic review.
    Zhou Y; van Melle M; Singh H; Hamilton W; Lyratzopoulos G; Walter FM
    BMJ Open; 2019 Oct; 9(10):e029143. PubMed ID: 31585970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender-specific differences in bladder cancer: a retrospective analysis.
    Horstmann M; Witthuhn R; Falk M; Stenzl A
    Gend Med; 2008 Dec; 5(4):385-94. PubMed ID: 19108811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria.
    Nilbert M; Bläckberg M; Ceberg J; Hagberg O; Stenhoff R; Liedberg F
    Scand J Urol; 2018 Aug; 52(4):237-243. PubMed ID: 30411661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients.
    Kluth LA; Rieken M; Xylinas E; Kent M; Rink M; Rouprêt M; Sharifi N; Jamzadeh A; Kassouf W; Kaushik D; Boorjian SA; Roghmann F; Noldus J; Masson-Lecomte A; Vordos D; Ikeda M; Matsumoto K; Hagiwara M; Kikuchi E; Fradet Y; Izawa J; Rendon R; Fairey A; Lotan Y; Bachmann A; Zerbib M; Fisch M; Scherr DS; Vickers A; Shariat SF
    Eur Urol; 2014 Nov; 66(5):913-9. PubMed ID: 24331151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
    Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
    Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor.
    Hassan O; Murati Amador B; Lombardo KA; Salles D; Cuello F; Marwaha AS; Daniels MJ; Kates M; Bivalacqua TJ; Matoso A
    World J Urol; 2020 Feb; 38(2):389-395. PubMed ID: 31030230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder.
    Supit W; Mochtar CA; Santoso RB; Umbas R
    Asian J Surg; 2014 Oct; 37(4):184-9. PubMed ID: 24637186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France].
    Rouprêt M; Malavaud B; Molinier L; Leleu H; Blachier M; Marteau F
    Prog Urol; 2015 Apr; 25(5):256-64. PubMed ID: 25605343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non-muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance Project.
    Hurle R; Colombo P; Lazzeri M; Lughezzani G; Buffi NM; Saita A; Elefante GM; Morenghi E; Forni G; Cardone P; Lista G; Maffei D; Guazzoni G; Casale P
    Eur Urol Oncol; 2018 Oct; 1(5):437-442. PubMed ID: 31158085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
    Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
    J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.
    Turker P; Bostrom PJ; Wroclawski ML; van Rhijn B; Kortekangas H; Kuk C; Mirtti T; Fleshner NE; Jewett MA; Finelli A; Kwast TV; Evans A; Sweet J; Laato M; Zlotta AR
    BJU Int; 2012 Sep; 110(6):804-11. PubMed ID: 22321341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.